Search results
Results from the WOW.Com Content Network
Meloxicam, sold under the brand name Mobic among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation in rheumatic diseases and osteoarthritis. [ 9 ] [ 10 ] It is taken by mouth or given by injection into a vein .
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...
Off-label promotion Depakote: False Claims Act, FDCA 2009 Eli Lilly [9] $1.4 billion Off-label promotion Zyprexa: False Claims Act, FDCA 2001 TAP Pharmaceutical Products [10] $875 million Medicare fraud, kickbacks Lupron: False Claims Act, Prescription Drug Marketing Act: 2012 Amgen [11] $762 million Off-label promotion, kickbacks Aranesp ...
This class action lawsuit was brought against the energy drink manufacturer, alleging they have citric acid in their drinks though the label on the cans promote “no preservatives.”
Targeting selectivity for COX-2 reduces the risk of peptic ulceration and is the main feature of celecoxib, rofecoxib, and other members of this drug class. [ 1 ] After several COX-2–inhibiting drugs were approved for marketing, data from clinical trials revealed that COX-2 inhibitors caused a significant increase in heart attacks and strokes ...
Meloxicam is a non-steroidal anti-inflammatory drug that is approved in the U.S. for a single post-operative injection in cats. [21] As of May 2013, the FDA issued a boxed warning regarding the use of thyroid hormone stimulating agents in treatment of obesity. [22] Data does not indicate any benefits to using these agents for weight loss.
PlayStation 3 system software#Class action suit filed over update 3.0; PlayStation 3 system software#Class action suits filed over update 3.21; PlayStation Network outage#Legal action against Sony; Polybutylene#Class action lawsuits and removal from building code approved usage; R2C2#Class action lawsuit; Raytheon#Securities litigation
In 2001, an 18-year-old committed to a Texas boot camp operated by one of Slattery’s previous companies, Correctional Services Corp., came down with pneumonia and pleaded to see a doctor as he struggled to breathe.